Old Drug Turned ' Cash Cow ' as Company Pumped Price to $40K a Vial Old Drug Turned ' Cash Cow ' as Company Pumped Price to $40K a Vial

Acthar was a"premium-priced product" with a"robust cash flow profile" that would help the company"achieve aspirational goals with a single transaction," according to internal discussions.Kaiser Health News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news